6-Methoxyflavone induces S-phase arrest through the CCNA2/CDK2/p21CIP1 signaling pathway in HeLa cells

Chaihong Zhang1,2, Yuchong Quan3, Lijuan Yang1,2

  • 1The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.

Bioengineered
|March 5, 2022
PubMed

Insights

6-Methoxyflavone inhibits cervical cancer cell proliferation by inducing S-phase arrest. This anticancer effect is mediated through the cyclin A2/cyclin-dependent kinase 2/p21CIP1 pathway, impacting cell cycle progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cervical cancer remains a significant global health concern, necessitating novel therapeutic strategies.
  • Understanding the molecular mechanisms underlying cancer progression is crucial for developing targeted treatments.
  • Flavonoids, like 6-methoxyflavone, are being investigated for their potential anticancer properties.

Purpose of the Study:

  • To elucidate the specific anticancer mechanism of 6-methoxyflavone in HeLa cervical cancer cells.
  • To identify the molecular targets and pathways affected by 6-methoxyflavone.
  • To investigate the interaction of 6-methoxyflavone with key cell cycle regulatory proteins.

Main Methods:

  • Utilized PharmMapper database for target identification, followed by microarray and transcriptome sequencing.
  • Performed functional and gene set enrichment analyses to explore target roles in cervical cancer.
  • Employed cell proliferation assays, cell cycle analysis, PCR, and Western blotting to confirm mechanisms.
  • Conducted molecular docking and noncovalent interaction analyses for structural validation.

Main Results:

  • Identified 178 putative targets for 6-methoxyflavone, with high mRNA expression of cyclin A2 (CCNA2) and cyclin-dependent kinase 2 (CDK2) linked to cervical cancer cell cycle progression.
  • 6-Methoxyflavone significantly inhibited HeLa cell proliferation and induced S-phase arrest.
  • The mechanism involves the CCNA2/CDK2/cyclin-dependent kinase inhibitor 1A (p21CIP1) pathway.
  • Molecular docking revealed strong affinity and inhibitory effects of 6-methoxyflavone on CDK2, enhanced by CCNA2 interaction.

Conclusions:

  • 6-Methoxyflavone exhibits anticancer activity in HeLa cells by inducing S-phase arrest.
  • The primary mechanism involves the modulation of the CCNA2/CDK2/p21CIP1 pathway, crucial for cell cycle regulation.
  • 6-Methoxyflavone demonstrates potential as a therapeutic agent for cervical cancer, warranting further investigation into its clinical relevance.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.3K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K